ClearPoint Neuro, Inc. (CLPT)
NASDAQ: CLPT · Real-Time Price · USD
11.92
+1.38 (13.09%)
At close: Aug 13, 2025, 4:00 PM
11.92
0.00 (0.00%)
Pre-market: Aug 14, 2025, 8:57 AM EDT
ClearPoint Neuro Market Cap
ClearPoint Neuro has a market cap or net worth of $338.81 million as of August 14, 2025. Its market cap has increased by 76.56% in one year.
Market Cap
338.81M
Enterprise Value
332.72M
1-Year Change
76.56%
Ranking
Category
Stock Price
$11.92
Market Cap Chart
Since May 22, 2012, ClearPoint Neuro's market cap has increased from $30.30M to $338.81M, an increase of 1,018.18%. That is a compound annual growth rate of 20.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 338.90M | -20.13% |
| Dec 31, 2024 | 424.30M | 153.77% |
| Dec 29, 2023 | 167.20M | -19.62% |
| Dec 30, 2022 | 208.00M | -21.57% |
| Dec 31, 2021 | 265.20M | -1.08% |
| Dec 31, 2020 | 268.10M | 267.26% |
| Dec 31, 2019 | 73.00M | 337.13% |
| Dec 31, 2018 | 16.70M | -41.61% |
| Dec 29, 2017 | 28.60M | 132.52% |
| Dec 30, 2016 | 12.30M | -56.84% |
| Dec 31, 2015 | 28.50M | -41.84% |
| Dec 31, 2014 | 49.00M | -42.22% |
| Dec 31, 2013 | 84.80M | 10.42% |
| Dec 31, 2012 | 76.80M | 153.47% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |